Miriam Estébanez

1.3k total citations
39 papers, 373 citations indexed

About

Miriam Estébanez is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Miriam Estébanez has authored 39 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 13 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Miriam Estébanez's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and HIV-related health complications and treatments (7 papers). Miriam Estébanez is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and HIV-related health complications and treatments (7 papers). Miriam Estébanez collaborates with scholars based in Spain, Austria and Chile. Miriam Estébanez's co-authors include Germán Ramírez‐Olivencia, José Ramón Arribas, Francisco Javier Membrillo de Novales, Rafael Rubio, Antonio Antela, Juan Pasquau, Ignacio Suárez-Lozano, José A. Pérez‐Molina, Ana Mariño and José Sanz and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Miriam Estébanez

37 papers receiving 363 citations

Peers

Miriam Estébanez
Miriam Estébanez
Citations per year, relative to Miriam Estébanez Miriam Estébanez (= 1×) peers Teresa García-Benayas

Countries citing papers authored by Miriam Estébanez

Since Specialization
Citations

This map shows the geographic impact of Miriam Estébanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Estébanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Estébanez more than expected).

Fields of papers citing papers by Miriam Estébanez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Estébanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Estébanez. The network helps show where Miriam Estébanez may publish in the future.

Co-authorship network of co-authors of Miriam Estébanez

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Estébanez. A scholar is included among the top collaborators of Miriam Estébanez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Estébanez. Miriam Estébanez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calle, Fernando, Miriam Estébanez, Marta Díaz‐Menéndez, et al.. (2023). Treatment and prevention of monkeypox. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(10). 629–634. 9 indexed citations
2.
Calle, Fernando, Miriam Estébanez, Marta Díaz‐Menéndez, et al.. (2022). Tratamiento y prevención de la viruela del mono. Enfermedades Infecciosas y Microbiología Clínica. 41(10). 629–634. 2 indexed citations
3.
Villatoro, Jaime Monserrat, Irene García-García, Rafael de la Cámara, et al.. (2020). Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol. BMJ Open. 10(10). e037443–e037443. 8 indexed citations
4.
Ramírez‐Olivencia, Germán, et al.. (2018). Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia. Enfermedades Infecciosas y Microbiología Clínica. 37(9). 602–608. 25 indexed citations
6.
Núñez, María Angélica Rivera, et al.. (2015). Motivos de consulta de pacientes con enfermedades autoinmunes sistémicas en el servicio de urgencias de un hospital terciario. Revista médica de Chile. 143(12). 1546–1551.
7.
Hernández‐Novoa, Beatriz, Nadia Madrid-Elena, Fernando Dronda, et al.. (2014). Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients. Journal of Antimicrobial Chemotherapy. 69(7). 1916–1919. 5 indexed citations
8.
Valero, Ignacio, Miriam Estébanez, Susana Monge, et al.. (2014). A Prospective Cohort Study of Neurocognitive Function in Aviremic HIV-Infected Patients Treated With 1 or 3 Antiretrovirals. Clinical Infectious Diseases. 59(11). 1627–1634. 17 indexed citations
9.
Estébanez, Miriam, Natalia Stella-Ascariz, Jesús Mingorance, et al.. (2014). A Comparative Study of Neurocognitively Impaired Patients Receiving Protease Inhibitor Monotherapy or Triple-Drug Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(4). 419–423. 4 indexed citations
10.
Estébanez, Miriam, Natalia Stella-Ascariz, Jesús Mingorance, et al.. (2014). Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study. BMC Infectious Diseases. 14(1). 379–379. 11 indexed citations
11.
Carvajal, Fernando, Carmen Bayón, Ignacio Valero, et al.. (2014). Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study. Journal of NeuroVirology. 20(4). 362–370. 7 indexed citations
12.
Estébanez, Miriam, et al.. (2012). Actualización en la patología pulmonar relacionada con la infección VIH. Archivos de Bronconeumología. 48(4). 126–132. 5 indexed citations
13.
Estébanez, Miriam & José Ramón Arribas. (2012). Protease Inhibitor Monotherapy: What Is Its Role?. Current HIV/AIDS Reports. 9(2). 179–185. 7 indexed citations
14.
Estébanez, Miriam, Natalia Stella-Ascariz, & José Ignacio Bernardino. (2012). Infección por el virus de la inmunodeficiencia humana tipo 1 e inflamación persistente: ¿es la traslocación bacteriana la causa oculta?. Medicina Clínica. 138(15). 673–677. 1 indexed citations
15.
Estébanez, Miriam, et al.. (2010). Enfermedad desmielinizante en pacientes infectados por el virus de la inmunodeficiencia humana sin inmunodepresión severa. Enfermedades Infecciosas y Microbiología Clínica. 28(9). 608–611.
16.
Estébanez, Miriam, et al.. (2009). Floración de las especies de interés apícola en el noroeste de Santa Cruz, Argentina. Boletín de la Sociedad Argentina de Botánica. 44. 393–403. 4 indexed citations
17.
Blázquez‐Gamero, Daniel, et al.. (2009). Brain abscess and epidural empyema caused by Salmonella enteritidisin a child: successful treatment with ciprofloxacin: a case report. Cases Journal. 2(1). 7131–7131. 9 indexed citations
18.
Estébanez, Miriam, Jorge Gómez Cerezo, & Fernando Hernández. (2007). El espectro de la fiebre mediterránea familiar. Revista Clínica Española. 207(10). 508–509. 7 indexed citations
19.
Estébanez, Miriam, et al.. (2007). Enfermedad de Crohn: ¿todavía hoy causa de fiebre de origen desconocido clásica?. Anales de Medicina Interna. 24(4). 185–6. 2 indexed citations
20.
Gómez-Cerezo, J.F., et al.. (2007). The Role of Endothelial Progenitor Cells and Statins in Endothelial Function: A Review. Cardiovascular & Hematological Agents in Medicinal Chemistry. 5(4). 265–272. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026